title: Does pre- and postoperative metronidazole treatment lower vaginal cuff infection rate after abdominal hysterectomy among women with bacterial vaginosis?
abstract: OBJECTIVE
  Bacterial vaginosis (BV) is a known risk factor for postoperative infection following abdominal hysterectomy. Vaginal bacterial flora scored as intermediate has been shown to have the same risk of postoperative infection as BV.
  
  
  METHODS
  Women undergoing total abdominal hysterectomy for benign diseases were open-randomized according to Zelen to either treatment with metronidazole rectally for at least 4 days or no treatment. At the preoperative gynecological examination a vaginal smear was collected and Gram stained. Women with BV or intermediate flora were merged to one group called abnormal vaginal flora.
  
  
  RESULTS
  In total 213 women were randomized to treatment or no treatment. After exclusion of 71 women, 142 women were eligible for analysis. Among the 59 women diagnosed with abnormal vaginal flora there were no vaginal cuff infections in the treated arm, compared with 27% in the 'no treatment' arm (p < 0.01). Treatment also reduced the vaginal cuff infection rate from 9.5 to 2% among the 83 women with lactobacilli flora. However, this difference was not statistically significant. Treatment had no effect on the rate of wound infections. Intention-to-treat analysis showed a significant reduction in vaginal cuff infections among women randomized to treatment.
  
  
  CONCLUSIONS
  Pre- and postoperative treatment for at least 4 days with metronidazole rectally reduces significantly vaginal cuff infection among women with abnormal vaginal flora.
authors.affiliation: Department of Obstetrics and Gynecology, Kärnsjukhuset, S-541 85 Skövde, Sweden. p-g.larsson@vgregion.se
authors.forename: Per-Göran
authors.initials: PG
authors.lastname: Larsson
authors.forename: Bodil
authors.initials: B
authors.lastname: Carlsson
mesh_terms: D000285:Administration, Rectal; D000328:Adult; D000704:Analysis of Variance; D019072:Antibiotic Prophylaxis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy / Q000379:methods*; D015994:Incidence; D016015:Logistic Models; D008795:Metronidazole / Q000008:administration & dosage*; D008875:Middle Aged; D011184:Postoperative Period; D011300:Preoperative Care / Q000379:methods; D011336:Probability; D012016:Reference Values; D018570:Risk Assessment; D013530:Surgical Wound Infection / Q000453:epidemiology / Q000517:prevention & control*; D016896:Treatment Outcome; D014591:Uterine Diseases / Q000150:complications / Q000473:pathology / Q000601:surgery*; D016585:Vaginosis, Bacterial / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D008795:Metronidazole